DermaCare Biosciences, LTD.

Warning LetterOpen

United StatesIssued Dec 1, 2021Center for Devices and Radiological Health

View Letter

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations0

Issue DateDec 1, 2021

Product TypeMedical Devices

StatusOpen

Letter Details

Firm: DermaCare Biosciences, LTD.
Location: United States
FEI Number: N/A
Country: United States
Issue Date: December 01, 2021
Issuing Office: Center for Devices and Radiological Health
Product Type: Medical Devices
Status: Open

Summary

Based on limited metadata, this FDA Warning Letter issued to DermaCare Biosciences, LTD. on December 1, 2021, concerns medical devices manufactured or distributed by the company. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's medical device regulatory authority, though the specific issuing office is not identified in this metadata. Further review of the complete warning letter would be necessary to identify the specific compliance issues cited.

DermaCare Biosciences, LTD. FDA Warning Letter, December 1, 2021